Zhejiang Jolly Pharmaceutical Co Ltd (300181) — Free Cash Flow Generation Index
Zhejiang Jolly Pharmaceutical Co Ltd (300181) has a Free Cash Flow Generation Index of 0.95x as of June 2025. Free cash flow of CN¥347.08 Million represents 1% of operating cash flow (CN¥367.02 Million). Read Zhejiang Jolly Pharmaceutical Co Ltd (300181) financial obligations for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Zhejiang Jolly Pharmaceutical Co Ltd Free Cash Flow Generation Index (2007–2025)
Historical FCF Generation Index trend for Zhejiang Jolly Pharmaceutical Co Ltd across 19 annual periods. Explore Zhejiang Jolly Pharmaceutical Co Ltd capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Zhejiang Jolly Pharmaceutical Co Ltd (2007–2025)
Year-by-year Free Cash Flow Generation Index for Zhejiang Jolly Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Zhejiang Jolly Pharmaceutical Co Ltd (300181) market capitalisation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.30x | CN¥124.66 Million | CN¥411.80 Million | CN¥287.14 Million | ▲ +163.2% |
| 2024 | 0.11x | CN¥34.16 Million | CN¥297.05 Million | CN¥262.89 Million | ▼ -78.8% |
| 2023 | 0.54x | CN¥156.75 Million | CN¥288.46 Million | CN¥131.71 Million | ▲ +23.2% |
| 2022 | 0.44x | CN¥140.56 Million | CN¥318.59 Million | CN¥178.03 Million | ▲ +7.0% |
| 2021 | 0.41x | CN¥103.84 Million | CN¥251.80 Million | CN¥147.95 Million | ▼ -47.9% |
| 2020 | 0.79x | CN¥221.34 Million | CN¥279.69 Million | CN¥58.35 Million | ▲ +15.3% |
| 2019 | 0.69x | CN¥88.48 Million | CN¥128.94 Million | CN¥40.46 Million | ▲ +171.0% |
| 2018 | -0.97x | CN¥-75.64 Million | CN¥78.28 Million | CN¥153.92 Million | ▲ +94.7% |
| 2017 | -18.12x | CN¥-117.89 Million | CN¥6.51 Million | CN¥124.40 Million | ▼ -1143.8% |
| 2016 | -1.46x | CN¥-84.94 Million | CN¥58.30 Million | CN¥143.24 Million | ▼ -299.2% |
| 2015 | 0.73x | CN¥71.04 Million | CN¥97.13 Million | CN¥26.08 Million | ▲ +139.1% |
| 2014 | -1.87x | CN¥-25.60 Million | CN¥13.70 Million | CN¥39.30 Million | ▼ -1055.4% |
| 2013 | 0.20x | CN¥5.77 Million | CN¥29.50 Million | CN¥23.73 Million | ▲ +191.3% |
| 2012 | -0.21x | CN¥-6.54 Million | CN¥30.51 Million | CN¥37.05 Million | ▲ +93.9% |
| 2011 | -3.49x | CN¥-47.67 Million | CN¥13.65 Million | CN¥61.32 Million | ▼ -966.6% |
| 2010 | 0.40x | CN¥26.10 Million | CN¥64.78 Million | CN¥38.68 Million | ▼ -27.2% |
| 2009 | 0.55x | CN¥24.30 Million | CN¥43.89 Million | CN¥19.60 Million | ▼ -7.6% |
| 2008 | 0.60x | CN¥18.66 Million | CN¥31.16 Million | CN¥12.50 Million | ▲ +38.7% |
| 2007 | 0.43x | CN¥6.93 Million | CN¥16.05 Million | CN¥9.12 Million | — |